AstraZeneca on expanding its diabetes research franchiseAstraZeneca is hoping to build a strong focus on cardiovascular, renal, and metabolic (CVRM) diseases. Richard Staines spoke Share XAstraZeneca on expanding its diabetes research franchisehttps://deep-dive.pharmaphorum.com/magazine/research-and-development-disruption-2020/astrazeneca-takes-on-cvrm/
Could AI create a brave new world of pharma R&D?Barely a week goes by without one big pharma or biotech announcing that it is using AI to Share XCould AI create a brave new world of pharma R&D?https://deep-dive.pharmaphorum.com/magazine/digital-health/ai-pharma-rd/
